What are the types of stem cells?

Stem cells are broadly categorized into Embryonic Stem Cells (ESCs), Adult Stem Cells (ASCs), and Induced Pluripotent Stem Cells (iPSCs). ESCs are pluripotent, derived from embryos, and can form any cell type. ASCs are multipotent or unipotent, found in adult tissues, and have limited differentiation potential. iPSCs are reprogrammed adult cells that regain pluripotency, offering patient-specific and ethically less controversial options.

How do stem cells work in regenerative medicine?

In regenerative medicine, stem cells work by replacing damaged or diseased cells and tissues. They can be introduced into the body, where they either differentiate into the required cell types to repair the injury or secrete growth factors and immunomodulatory molecules that promote the body's natural healing processes. This aims to restore function to organs or tissues compromised by disease or trauma, such as in spinal cord injury or heart damage.

What are the ethical concerns with stem cell research?

Ethical concerns primarily revolve around the use of embryonic stem cells, as their derivation involves the destruction of a human embryo. Other concerns include the potential for commercial exploitation of unproven therapies, informed consent issues, the creation of human-animal chimeras, and the moral status of human embryos. Induced pluripotent stem cells (iPSCs) largely circumvent the ethical issues associated with embryo destruction.

Which diseases can be treated with stem cell therapy?

Currently, hematopoietic stem cell transplantation (HSCT) is an approved and widely used therapy for various blood cancers (leukemia, lymphoma), aplastic anemia, and certain immune disorders. For most other conditions like Parkinson's disease, spinal cord injury, diabetes, and heart disease, stem cell therapies are still largely experimental and are being investigated in clinical trials globally, with no widespread regulatory approval for routine clinical use outside of specific trial protocols.

What are ICMR guidelines for stem cell research?

The ICMR National Guidelines for Stem Cell Research, 2017 (and updates), provide a comprehensive regulatory framework for India. They prohibit reproductive cloning, regulate therapeutic cloning, restrict embryo research to 14 days, mandate CTRI registration for clinical trials, and strictly prohibit the use of unproven stem cell therapies outside approved research protocols. They emphasize ethical oversight, patient safety, and scientific rigor.

How are induced pluripotent stem cells created?

Induced pluripotent stem cells (iPSCs) are created by genetically reprogramming adult somatic cells, typically skin fibroblasts. This involves introducing specific 'Yamanaka factors' (transcription factors like Oct4, Sox2, Klf4, and c-Myc) into the cells, often via viral vectors. These factors induce epigenetic changes that revert the adult cell to an embryonic-like pluripotent state, capable of differentiating into various cell types.

What are the current applications of stem cell technology?

Current approved applications are primarily hematopoietic stem cell transplants for blood disorders. Experimental applications, under clinical trials, include therapies for neurological disorders (Parkinson's, spinal cord injury), cardiac repair, diabetes, and ocular diseases. Stem cells are also widely used in disease modeling, drug discovery, and toxicology testing, particularly through iPSC-derived organoids, to understand human biology and develop new treatments.

← ALL TOPICS

Science & Technology

NEXT TOPIC →

Vaccines and Immunotherapy

Stem Cell Technology

Q: What is the difference between embryonic and adult stem cells?

Embryonic stem cells (ESCs) are pluripotent, derived from early embryos, and can differentiate into almost any cell type, but their use raises ethical issues. Adult stem cells (ASCs) are multipotent or unipotent, found in various adult tissues, have limited differentiation capacity, and are ethically less controversial. iPSCs bridge this gap, offering pluripotency without embryo destruction.

Science & Technology

Constitution VerifiedUPSC Verified

Version 1Updated 10 Mar 2026

Explore This Topic

Definition Detailed Explanation Key Discoveries Scientific Principles Tech Evolutions UPSC Importance Prelims Strategy Mains Strategy Prelims MCQs Mains Questions MCQ Practice Predicted 2026 Revision Notes Current Affairs

The National Guidelines for Stem Cell Research, 2017, issued by the Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT), serve as the primary regulatory framework governing all aspects of stem cell research and therapy in India. These comprehensive guidelines underscore the immense therapeutic potential of stem cells while simultaneously emphasizing the critical nee…

Quick Summary

Stem cell technology is a rapidly evolving field in medical biotechnology, centered on cells with two defining characteristics: self-renewal (ability to make copies of themselves) and potency (ability to differentiate into specialized cell types).

These fundamental properties make stem cells invaluable for regenerative medicine, where the goal is to repair or replace damaged tissues and organs. The three main types are Embryonic Stem Cells (ESCs), Adult Stem Cells (ASCs), and Induced Pluripotent Stem Cells (iPSCs).

ESCs are pluripotent, capable of forming any cell type in the body, but their use is ethically contentious due to embryo destruction. ASCs are multipotent or unipotent, found in various adult tissues, and are less controversial but have limited differentiation potential.

iPSCs are a breakthrough, as they are adult cells reprogrammed to an ESC-like pluripotent state, bypassing ethical concerns and offering patient-specific therapeutic avenues. The mechanism of differentiation involves complex signaling pathways and epigenetic modifications, while reprogramming involves specific transcription factors like the Yamanaka factors.

Therapeutically, the most established application is hematopoietic stem cell transplantation for blood disorders. Other applications for neurological, cardiac, and autoimmune diseases are largely in experimental clinical trials.

In India, the ICMR National Guidelines for Stem Cell Research, 2017, provide a strict regulatory framework, emphasizing ethical conduct, patient safety, and the prohibition of unproven therapies. From a UPSC perspective, understanding the types, mechanisms, applications, and the ethical-regulatory landscape, particularly in India, is crucial for analyzing this high-impact scientific domain.

Vyyuha

Your 6-Month Blueprint, Updated Nightly

AI analyses your progress every night. Wake up to a smarter plan. Every. Single.…

Key facts, numbers, article numbers in bullet format.

Stem Cell Properties — Self-renewal, Potency (Pluripotent, Multipotent, Unipotent).

Types — Embryonic Stem Cells (ESCs), Adult Stem Cells (ASCs), Induced Pluripotent Stem Cells (iPSCs).

ESCs — Pluripotent, from blastocyst, ethical issues.

ASCs — Multipotent/Unipotent, from adult tissues, e.g., Hematopoietic Stem Cells (HSCs).

iPSCs — Pluripotent, reprogrammed adult cells, Yamanaka factors (Oct4, Sox2, Klf4, c-Myc), less ethical concern.

Approved Therapy — Hematopoietic Stem Cell Transplantation (HSCT) for blood disorders.

Indian Regulation — ICMR National Guidelines for Stem Cell Research, 2017.

Key ICMR Rules — Prohibits reproductive cloning, 14-day rule for embryo research, mandatory CTRI registration for trials, discourages unproven therapies.

Constitutional Links — Article 21 (Right to Health), Article 51A(h) (Scientific Temper).

Challenges — Tumorigenicity, immune rejection, efficacy, accessibility, ethics, unproven clinics.

STEM-CARE for Stem Cell Technology:

Self-renewal & Specialization (Potency)

Types: Embryonic, Adult, IPSCs

Ethics: Embryo, Unproven Therapies

Mechanisms: Differentiation, Reprogramming (Yamanaka Factors)

Clinical Use: HSCT (Approved), Others (Experimental)

Applications: Regenerative Medicine, Disease Models, Drug Discovery

Regulation: ICMR Guidelines (2017), CTRI, Article 21, 51A(h)

Experimental Challenges: Efficacy, Safety (Tumors), Accessibility

Stem Cell Technology

Quick Summary

Related Topics